Hacker News Reader

I don't believe the study is comparing absolute numbers, it's talking about risk on a per-individual level.

I didn't read the study, but the article talks about the number of cases during a four month period.

That's about how long the Pfizer-BioNTech reliably prevents infection in that cohort.